ArticleLeukemia2015
The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.
K Balakrishnan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
95 papers cite itlatest 60 shown
this paperpooled ittrialcites it